A. S. Khalansky
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
- Biomaterials 17
- Nanoparticle-Based Drug Delivery 17
-
- Nanoplatforms for cancer theranostics 8
- Graphene and Nanomaterials Applications 2
- Photoacoustic and Ultrasonic Imaging 2
- Co-authors
- Svetlana Gelperina (15 shared papers)Jörg Kreuter (8 shared papers)Reiner Uhl (2 shared papers)J. Kreuter (3 shared papers)Olga Maksimenko (3 shared papers)З. С. Смирнова (2 shared papers)Severin Se (2 shared papers)Igor Skidan (2 shared papers)
- Journals
- Journal of Controlled Release (2 papers)International Journal of Pharmaceutics (2 papers)Drug Delivery (1 paper)Journal of Microencapsulation (1 paper)PLoS ONE (1 paper)
- Partner nations
- RussiaGermanyUnited Kingdom
In The Last Decade
A. S. Khalansky
23 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 97
- Biomaterials 1.1k
- Pharmaceutical Science 409
- Genetics 183
- Biomedical Engineering 592
- Neurology 89
Countries citing papers authored by A. S. Khalansky
This map shows the geographic impact of A. S. Khalansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. S. Khalansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. S. Khalansky more than expected).
Fields of papers citing papers by A. S. Khalansky
This network shows the impact of papers produced by A. S. Khalansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. S. Khalansky. The network helps show where A. S. Khalansky may publish in the future.
Co-authors
The 25 scholars most cited alongside A. S. Khalansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 340 | |
| 2 | 2006 | 251 | |
| 3 | 2009 | 240 | |
| 4 | 2002 | 141 | |
| 5 | 2011 | 133 | |
| 6 | 2006 | 105 | |
| 7 | 2019 | 100 | |
| 8 | 2006 | 85 | |
| 9 | 2011 | 85 | |
| 10 | 2014 | 61 | |
| 11 | 2009 | 48 | |
| 12 | 2011 | 38 | |
| 13 | 2021 | 33 | |
| 14 | 2016 | 17 | |
| 15 | 2009 | 10 | |
| 16 | 2023 | 8 | |
| 17 | 2018 | 6 | |
| 18 | 1984 | 4 | |
| 19 | 1991 | 3 | |
| 20 | 2022 | 3 |
About A. S. Khalansky
A. S. Khalansky is a scholar working on Biomaterials, Biomedical Engineering, Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), Glioma Diagnosis and Treatment (9 papers), Nanoplatforms for cancer theranostics (8 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Graphene and Nanomaterials Applications (2 papers), Photoacoustic and Ultrasonic Imaging (2 papers), RNA Interference and Gene Delivery (2 papers) and Advanced Drug Delivery Systems (2 papers). The work is most often cited by research in Biomaterials (1.1k citations), Pharmaceutical Science (409 citations), Genetics (183 citations), Biomedical Engineering (592 citations) and Neurology (89 citations). A. S. Khalansky has collaborated with scholars based in Russia, Germany and United Kingdom. Frequent co-authors include Svetlana Gelperina, Jörg Kreuter, Reiner Uhl, J. Kreuter, Olga Maksimenko, З. С. Смирнова, Severin Se, Igor Skidan, Telli Hekmatara and David J. Begley. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Drug Delivery, Journal of Microencapsulation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.